Title : A proof of concept on the effects of traditional dietary patterns (Mediterranean vs Milpa) on cardiometabolic markers in subjects with hypertriglyceridemic waist
Abstract:
The prevalence of overweight and obesity in the Mexican adult population is ~75. The increased adiposity, particularly that located within the waistline is associated with low-grade inflammation which, in turn, detonates the development of cardiometabolic disorders, especially hypertriglyceridemia. Mediterranean diet has been stated as the reference therapeutic as it is associated with lower levels of inflammation and lower cardiovascular risk, however, the type of eating pattern is not always accessible in our population, so a diet with traditional Mexican foods (Milpa Diet) could provide a therapeutic measure in obesity and its cardiometabolic alterations, also mediating the underlying basis. To demonstrate the effectiveness of such diet, we conducted a clinical trial comparing the cardiometabolic profile in subjects presenting abdominal obesity and hypertriglyceridemia. They underwent dietary treatment with either Mediterranean or Milpa patterns for 3 months. Anthropometrics, bioelectrical parameters, and biochemical indicators were evaluated at the beginning and end of dietary treatment.
Results: both traditional dietary patterns resulted in significant improvements in glycemic control, lipemia, cardiometabolic risk index (TG/HDL); body fat and visceral adipose area were significantly decreased whilst phase angle did not change; patients presented a decrease of 10 and 2% in both systolic and diastolic blood pressures, respectively. There was no difference between diet effectiveness.
Audience Take Away:
- We aim to enhance the inclusion of traditional foos within diet plans prescribed on the daily clinical setting.
- By favoring traditional diets, adherence increases (due to idiosyncrasy) thus therapeutic effect is improved.
- Hypertriglyceridemia is the most frequent dyslipidemia and, in the combination with abdominal obesity, cardiometabolic risk is significantly increased.
